Ram Chandra Bhandari
Pharma
Vega Pharmaceuticals
Nepal
Biography
Mr. Ram Chandra Bhandari ,managing director,Vega Pharmaceuticals
Research Interest
Pharmaceutical sciences
Global
Pharmaceutical Sciences Experts
Recommended Journals
- Biomedicine Journal
- Pharmaceutical Analysis Journal
- Proteomics Journal
- Data Mining Journal
- Molecular Medicine Journal
- Pharmacovigilance Journal
- Pharmacoepidemiology Journal
- Clinical Toxicology Journal
- Drug Safety Journal
- Community Medicine Journal
- Health Care Journal
- Pharmaceutical Regulatory Affairs Journals
- Drug Designing Journals
Recommended Conferences
-
9th Asian Biologics and Biosimilars Congress
August 20-21, 2018 Tokyo, Japan
-
International Conference & Exhibition on Drug Safety and Pharmacovigilance
August 29-30, 2018 Toronto,Canada Toronto, Canada
-
International Conference And Exhibition on Drug Safety & Pharmacovigilance
August 29-30, 2018 Toronto, Canada
-
International Conference And Exhibition on Drug Safety & Pharmacovigilance
August 29-30, 2018 Toronto, Canada
-
6th European Biopharma Congress
September 18-19, 2018 Amsterdam, Netherlands
-
6th European Biopharma Congress
September 18-19, 2018 Amsterdam, Netherlands
-
18th World Pharma Congress
October 18-19, 2018 Warsaw, Poland
-
18th World Pharma Congress
October 18-20, 2018 Warsaw, Poland
-
3rd International Conference on Pharmaceutical Chemistry
October 29-31, 2018 Brussels, Belgium
-
18th Annual Pharmaceutical Chemical Analysis Congress
November 05-06, 2018 Madrid, Spain
Relevant Topics
- Advances in Bioavailability
- American Health Care Systems
- Anvisa Bioequivalence
- Australian Health Care Systems
- BA/BE Studies
- Biochemical Metabolism
- Bioequivalence Anticancers
- Bioequivalence Antidiabetics
- Bioequivalence Antidiuretics
- Bioequivalence Antipsychotics
- Bioequivalence Cardiovascular Products
- Bioequivalence Study Design
- Bioequivalence Study Protocols
- Biosimilars
- Canadian Health Care Systems
- Cancer Pharmacogenomics
- Clinical Cancer Trials
- Clinical Drug Trial
- Clinical Management Systems
- Clinical Pharmacogenomics
- Cytochrome 450 Drug Metabolism
- Cytotoxicity
- Detoxification
- Drug Dosage Formulations
- Drug drug interaction
- Drug food interaction
- Drug Interaction
- Drug Toxicity and Efficacy
- Drug Toxicology
- Drugs metabolised by CYP2D6
- Epigenomic studies
- European Bioequivalence
- Europian Health Care Systems
- Experimental Drug Trial
- FDA Bioequivalence
- Gene polymorphism
- Genomic Targets
- Health Care Management Systems
- Health Information Systems
- Health Insurance Systems
- Health Polices
- Health Systems
- Health Systems Services
- Hepatic Metabolism of Drugs
- Immune Disorders
- In vitro Bioequivalence
- Individualized Medicine
- Japan Health Care Systems
- Liver Drug Metabolism
- Medical Billing Softwares
- Medical Software Companies and Software Analysis
- Medication Management Services
- Observatory Health Policies
- Online Pharmacy
- Paid Clinical Trials
- Personalized Medicine Studies
- Pharmaceutical Care Management
- Pharmaceutical Care Models
- Pharmaceutical Care Practice
- Pharmaceutical Toxicology
- Pharmacoeconomics in Drug Development
- Pharmacogenetics
- Pharmacogenomic Biomarker
- Pharmacogenomics and Personalized Medicine
- Pharmacogenomics Applications
- Pharmacogenomics for Patient Care
- Pharmacogenomics Future Medicine
- Pharmacoproteomics in Drug development
- Pharmacy Education
- Pharmacy Practice
- Phase I Drug Metabolism
- Phase II Drug Metabolism
- Proteomics and Pharmacodynamics
- Regulatory Requirements in Bioequivalence
- Translational Medicine